1993
DOI: 10.1002/jps.2600820909
|View full text |Cite
|
Sign up to set email alerts
|

Development of a New Drug Carrier Made from Alginate

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
192
0
2

Year Published

1999
1999
2017
2017

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 368 publications
(197 citation statements)
references
References 17 publications
3
192
0
2
Order By: Relevance
“…22 Alginate is widely used in the food industry as a thickening agent and stabilizer and in the pharmaceutical industry as drug carriers. [24][25][26] NOM was found to strongly interact with NPs in suspension through electrostatic forces and steric interactions, thus modifying significantly their transport and bioavailability. Once the surface is coated with natural polymers or humic substances, the NPs are stabilized against aggregation except in the presence of divalent salts which are found to promote aggregation via bridging mechanisms.…”
Section: Introductionmentioning
confidence: 99%
“…22 Alginate is widely used in the food industry as a thickening agent and stabilizer and in the pharmaceutical industry as drug carriers. [24][25][26] NOM was found to strongly interact with NPs in suspension through electrostatic forces and steric interactions, thus modifying significantly their transport and bioavailability. Once the surface is coated with natural polymers or humic substances, the NPs are stabilized against aggregation except in the presence of divalent salts which are found to promote aggregation via bridging mechanisms.…”
Section: Introductionmentioning
confidence: 99%
“…In the CaA complex, the calcium ions interact mainly with oligopolyguluronic sequences of the alginate, producing an 'egg-box' structure (Grant et al, 1973). As alginates are negatively charged polymers, they form preferentially at the level of the mannuronic sequences complexes with cationic compounds (chlorpheniramine, doxorubicin, propranolol) (Stockwell et al, 1986;Segi et al, 1989;Rajaonarivony et al, 1993), as well as with polycations (polysaccharides, polypeptides, or synthetic polymers) (Bystricky et al, 1990;Thu et al, 1996;Gombotz & Wee, 1998;Coppi et al, 2004). An alginate with high mannuronic content was used in a previous work to design a biodegradable intra-operative system releasing gentamicin for bone infection treatment.…”
Section: Introductionmentioning
confidence: 99%
“…Introduction of the cationic polymer (chitosan, poly-L-arginine or poly-L-lysine) can adjust the size of the particles formed. For example, 250-850 nm (depending on the alginate concentration) particles were synthesized as drug carriers; these particles are formed in solution by adding sodium alginate, calcium chloride and then poly-L-lysine [43]. The particle size can also be controlled by the volume of "nanoreactors" (micelles); reverse micelles were successfully used to synthesize nanocarriers (from alginate and calcium salts) with an average size of about 80 nm in diameter exhibiting a high degree of endocytosis by NIH 3T3 cells [44].…”
Section: The Hypothesis Assessment and Reviewmentioning
confidence: 99%